139 related articles for article (PubMed ID: 9527400)
1. Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
Drukker A; Eddy AA
J Am Soc Nephrol; 1998 Feb; 9(2):243-51. PubMed ID: 9527400
[TBL] [Abstract][Full Text] [Related]
2. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
Magil A
J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
[TBL] [Abstract][Full Text] [Related]
4. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
Hirano T; Mamo JC; Nagano S; Sugisaki T
Nephron; 1991; 58(1):95-100. PubMed ID: 1857487
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis.
Hirano T; Morohoshi T
Nephron; 1992; 60(4):443-7. PubMed ID: 1584321
[TBL] [Abstract][Full Text] [Related]
6. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
7. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
[TBL] [Abstract][Full Text] [Related]
8. Effect of dietary antioxidants on puromycin aminonucleoside nephrotic syndrome.
Pedraza-Chaverri J; Arévalo AE; Hernández-Pando R; Larriva-Sahd J
Int J Biochem Cell Biol; 1995 Jul; 27(7):683-91. PubMed ID: 7648424
[TBL] [Abstract][Full Text] [Related]
9. Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome.
Eddy AA
Am J Physiol; 1994 Jun; 266(6 Pt 2):F884-93. PubMed ID: 8023968
[TBL] [Abstract][Full Text] [Related]
10. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
Tofovic SP; Rominski BR; Bastacky S; Jackso EK; Kost CK
Ren Fail; 2000 Mar; 22(2):159-79. PubMed ID: 10803761
[TBL] [Abstract][Full Text] [Related]
11. Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades.
Eddy AA
Kidney Int; 1998 May; 53(5):1182-9. PubMed ID: 9573532
[TBL] [Abstract][Full Text] [Related]
12. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic N; Singal PK
Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
[TBL] [Abstract][Full Text] [Related]
13. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
Yamanaka M; Tamura Y; Kuribayashi-Okuma E; Uchida S; Shibata S
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F168-F178. PubMed ID: 36454699
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Kidney Int; 1991 Dec; 40(6):1020-31. PubMed ID: 1762303
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
Kawamorita Y; Shiraishi T; Tamura Y; Kumagai T; Shibata S; Fujigaki Y; Hosoyamada M; Nakagawa T; Uchida S
Physiol Rep; 2017 Aug; 5(15):. PubMed ID: 28774949
[TBL] [Abstract][Full Text] [Related]
16. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
17. Dietary vitamin E supplementation ameliorates renal injury in chronic puromycin aminonucleoside nephropathy.
Trachtman H; Schwob N; Maesaka J; Valderrama E
J Am Soc Nephrol; 1995 Apr; 5(10):1811-9. PubMed ID: 7787149
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.
Park YS; Guijarro C; Kim Y; Massy ZA; Kasiske BL; Keane WF; O'Donnell MP
Am J Kidney Dis; 1998 Jan; 31(1):190-4. PubMed ID: 9428473
[TBL] [Abstract][Full Text] [Related]
19. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.
Eddy AA; McCulloch L; Liu E; Adams J
Am J Pathol; 1991 May; 138(5):1111-23. PubMed ID: 2024704
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
